)
Visual24 Oct 2025
The rise of Alphabet
BioPharma Credit (BPCR) investor relations material
BioPharma Credit H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary22 Sep, 2025
Executive summary
Portfolio valued at $1.2bn across 15 transactions as of September 2025, focused on senior secured loans to commercial-stage life sciences companies.
Achieved net income of $72.8m for H1 2025, with net income per share rising to $0.0633 from $0.0576 year-over-year.
Consistent annualized dividends per share since IPO, with interim dividends meeting the $0.070 target for nearly seven years.
Investment manager Pharmakon Advisors has a strong track record, with $10.3bn committed across 65 investments and a 10.3% unlevered weighted average net IRR on four fully realized private funds.
Returned $89.5m to shareholders via dividends and share buybacks, representing 7.8% of NAV.
Financial highlights
Net income per share rose to $0.0633 as of 30 June 2025, up from $0.0576 year-over-year.
NAV per share increased to $1.0186 from $0.9963 at year-end 2024.
Net assets stood at $1,150.3m, down from $1,181.7m at year-end 2024.
Share price remained flat at $0.8840, with a 13.2% discount to NAV.
Ongoing charges (excluding performance fee) were 0.6% of average net assets; including performance fee, 1.0%.
Outlook and guidance
Targeting a total net return on NAV of 8-9% per annum over the medium term.
Plans to continue paying a $0.07 annual dividend plus a variable special dividend.
$164m in cash available for new investments at 30 June 2025.
Investment pipeline expected to grow as new products and companies enter the market in H2 2025 and beyond.
Anticipates continued strong demand for non-dilutive debt as equity and convertible bond issuance remains subdued.
Capital allocation: buybacks vs. new investments?
Floating rate exposure: SOFR impact on income?
New investment pipeline and diversification strategy?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next BioPharma Credit earnings date
H2 202524 Mar, 2026
Next BioPharma Credit earnings date
H2 202524 Mar, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
BioPharma Credit PLC is an investment trust, primarily investing in interest-bearing debt assets. The company's assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in Exeter, United Kingdom
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage